Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers

Stephanie N. Hurwitz; Mark A. Rider; Joseph L. Bundy; Xia Liu; Rakesh K. Singh; David G. Meckes Jr.

doi:10.18632/oncotarget.13569

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers

Stephanie N. Hurwitz _, Mark A. Rider, Joseph L. Bundy, Xia Liu, Rakesh K. Singh and David G. Meckes Jr.

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:86999-87015. https://doi.org/10.18632/oncotarget.13569

Metrics: PDF 5178 views | HTML 9536 views | ?

Abstract

Stephanie N. Hurwitz1,*, Mark A. Rider1,*, Joseph L. Bundy1,*, Xia Liu1, Rakesh K. Singh1, David G. Meckes Jr.1

1Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL, 32306, USA

*These authors contributed equally to this work

Correspondence to:

David G. Meckes Jr., email: [email protected]

Keywords: exosomes, microvesicles, co-inertia, proteomics, biomarkers

Received: September 28, 2016 Accepted: November 07, 2016 Published: November 24, 2016

ABSTRACT

Packed with biological information, extracellular vesicles (EVs) offer exciting promise for biomarker discovery and applications in therapeutics and non-invasive diagnostics. Currently, our understanding of EV contents is confined by the limited cells from which vesicles have been characterized utilizing the same enrichment method. Using sixty cell lines from the National Cancer Institute (NCI-60), here we provide the largest proteomic profile of EVs in a single study, identifying 6,071 proteins with 213 common to all isolates. Proteins included established EV markers, and vesicular trafficking proteins such as Rab GTPases and tetraspanins. Differentially-expressed proteins offer potential for cancer diagnosis and prognosis. Network analysis of vesicle quantity and proteomes identified EV components associated with vesicle secretion, including CD81, CD63, syntenin-1, VAMP3, Rab GTPases, and integrins. Integration of vesicle proteomes with whole-cell molecular profiles revealed similarities, suggesting EVs provide a reliable reflection of their progenitor cell content, and are therefore excellent indicators of disease.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13569

Publication Alerts

Research Papers:

Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers

Abstract